Distribution of nodal metastases after chemotherapy in nonseminomatous testis cancer: A possible indication for limited dissection

BJU International

Volumn 97, Issue 6, 2006, Pages 1221-1224

  Ehrlich, Yaron ^b   Yossepowitch, Ofer ^b   Kedar, Daniel ^b   Baniel, Jack ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Chemotherapy; Metastases; Modified template; Retroperitoneal lymph node dissection; Testicular cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; AORTA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; INFERIOR CAVA VEIN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MEDICAL RECORD; NON SEMINOMATOUS GERMINOMA; PATHOLOGY; PRIORITY JOURNAL; TESTIS CANCER;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CISPLATIN; COMBINED MODALITY THERAPY; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASM, RESIDUAL; NEOPLASMS, GERM CELL AND EMBRYONAL; RETROPERITONEAL SPACE; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 33745201841     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06167.x     Document Type: Article

References (21)

1. Fizazi K, Tjulandin S, Salvioni R et al. Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy - results from an international study group. J Clin Oncol 2001 19: 2647 57
2. Wood DP Herr HW, Heller G et al. Distribution of retroperitoneal metastases after chemotherapy inpatients with nonseminomatous germ cell tumors. J Urol 1992 148: 1812 6
3. Oldenburg J, Alfsen GC, Lien HH, Aass N, Waehre H, Fossa SD. Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol 2003 21: 3310 7
4. Foster RS, Beck S, Bihrle R. Secondary surgery in germ cell tumors - when and how extensively should it be performed? World J Urol 2004 22: 37 40
5. Donohue JP, Zachary JM, Maynard BR. Distribution of nodal metastases in nonseminomatous testis cancer. J Urol 1982 128: 315 20
6. Weissbach L, Boedefeld EA. Localization of solitary and multiple metastases in stage II nonseminomatous testis tumor as basis for a modified staging lymph node dissection in stage I. J Urol 1987 138: 77 82
7. Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965-89): modifications of technique and impact on ejaculation. J Urol 1993 149: 237 43
8. Aprikian AG, Herr HW, Bajorin DF, Bosl GJ. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors. Cancer 1994 74: 1329 34
9. Coogan CL, Hejase MJ, Wahle GR et al. Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer. J Urol 1996 156: 1656 8
10. Jacobsen KD, Ous S, Waehre H et al. Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection. Br J Cancer 1999 80: 249 55
11. Ozen H, Ekici S, Sozen S, Ergen A, Tekgul S, Kendi S. Resection of residual masses alone: an alternative in surgical therapy of metastatic testicular germ cell tumors after chemotherapy. Urology 2001 57: 323 7
12. Sheinfeld J. The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: current concepts and controversies. Semin Urol Oncol 2002 20: 262 71
13. Gelderman WA, Koops HS, Sleijfer DT, Oosterhuis JW, Oldhoff J. Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors. Cancer 1986 58: 1418 21
14. Hendry WF, A'Hern RP, Hetherington JW, Peckham MJ, Dearnaley DP, Horwich A. Para-aortic lymphadenectomy after chemotherapy for metastatic non-seminomatous germ cell tumours. prognostic value and therapeutic benefit. Br J Urol 1993 71: 208 13
15. Hollins GW, Thomas S, Lanigan DJ et al. Retroperitoneal surgery: its wider role in the management of malignant teratoma. Br J Urol 1996 77: 571 6
16. Horwich A, Norman A, Fisher C, Hendry WF, Nicholls J, Dearnaley DP. Primary chemotherapy for stage II nonseminomatous germ cell tumors of the testis. J Urol 1994 151: 72 8
17. Suzuki K, Orikasa S, Hoshi S et al. The significance of resections for residual masses after chemotherapy in metastatic testicular tumors. Int J Urol 1999 6: 305 13
18. Rabbani F, Goldenberg SL, Gleave ME, Paterson RF, Murray N, Sullivan LD. Retroperitoneal lymphadenectomy for post-chemotherapy residual masses: is a modified dissection and resection of residual masses sufficient? Br J Urol 1998 81: 295 300
19. Herr HW. Does necrosis on frozen-section analysis of a mass after chemotherapy justify a limited retroperitoneal resection in patients with advanced testis cancer? Br J Urol 1997 80: 653 7
20. Beck SD, Foster RS, Bihrle R et al. Is full bilateral retroperitoneal lymph node dissection (RPLND) always necessary for post chemotherapy residual tumor? J Urol 2005 173 ( Suppl AUA abstract 117
21. Donohue JP, Roth LM, Zachary JM, Rowland RG, Einhorn LH, Williams SG. Cytoreductive surgery for metastatic testis cancer: tissue analysis of retroperitoneal masses after chemotherapy. J Urol 1982 127: 1111 4